Skip to main content
CRDF logo

CRDF · Cardiff Oncology, Inc.

Track CRDF — free
$0.92 +0.01 (+1.26%)
Market Cap
$71.36M
Shares
77.80M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-07-30 10,495 $0.81 $8,501
2026-07-29 31,833 $0.82 $26,103
2026-07-28 13,151 $0.84 $11,047
2026-07-27 4,908 $0.83 $4,074
2026-07-24 36,109 $0.84 $30,332
2026-07-23 4,049 $0.86 $3,482
2026-07-22 290 $0.84 $244
2026-07-21 60,649 $0.84 $50,945
2026-07-17 104,503 $0.87 $90,918
2026-07-16 32,138 $0.89 $28,603
2026-07-15 1 $1.31 $1
2026-07-13 5,266 $1.33 $7,004
2026-07-10 867 $1.32 $1,144
2026-07-08 3,704 $1.35 $5,000
2026-07-07 35,515 $1.30 $46,170
2026-07-06 23,875 $1.27 $30,321
2026-07-02 100 $1.29 $129
2026-07-01 239,107 $1.30 $310,839
2026-06-30 569,722 $1.27 $723,547
2026-06-29 575,885 $1.25 $719,856
2026-06-26 137,097 $1.21 $165,887
2026-06-25 22,208 $1.26 $27,982
2026-06-24 175,729 $1.25 $219,661
2026-06-23 486,672 $1.30 $632,674
2026-06-22 636,509 $1.21 $770,176
2026-06-18 37,219 $1.18 $43,918
2026-06-17 21,186 $1.26 $26,694
2026-06-16 131,416 $1.42 $186,611
2026-06-15 11,963 $1.54 $18,423
2026-06-12 364,673 $1.59 $579,830
2026-06-11 440,591 $1.48 $652,075
2026-06-10 108,688 $1.53 $166,293
2026-06-09 172,230 $1.50 $258,345
2026-06-08 914,490 $1.50 $1,371,735
2026-06-05 126,184 $1.55 $195,585
2026-06-04 194,701 $1.40 $272,581
2026-06-03 342,642 $1.51 $517,389
2026-06-02 207,771 $1.48 $307,501
2026-06-01 69,602 $1.90 $132,244
2026-05-29 147,150 $1.84 $270,756
2026-05-28 7,540 $1.81 $13,647
2026-05-27 32,008 $1.94 $62,096
2026-05-26 109,791 $1.78 $195,428
2026-05-22 25,931 $1.79 $46,416
2026-05-21 43,552 $1.84 $80,136
2026-05-20 8,893 $1.76 $15,652
2026-05-19 31,171 $1.69 $52,679
2026-05-18 13,486 $1.67 $22,522
Showing 1–48 of 48 settlements
Key facts CIK 1213037 CUSIP 14147L108 13F (30d) 98 filings 96 filers Visit website Investor relations